{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:04:26Z","timestamp":1790856266928,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K08567"],"award-info":[{"award-number":["JP22K08567"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K11691"],"award-info":[{"award-number":["JP25K11691"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s40266-025-01245-x","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T09:37:01Z","timestamp":1757929021000},"page":"1001-1009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Characteristics of Late-Onset Systemic Lupus Erythematosus: Clinical Manifestations and Diagnostic and Treatment Challenges"],"prefix":"10.1007","volume":"42","author":[{"given":"Natsuki","family":"Sakurai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3945-307X","authenticated-orcid":false,"given":"Ryusuke","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"1245_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/rheumatology\/ket330","volume":"53","author":"YM Chen","year":"2014","unstructured":"Chen YM, Lin CH, Chen HH, et al. Onset age affects mortality and renal outcome of female systemic lupus erythematosus patients: a nationwide population-based study in Taiwan. Rheumatology (Oxford). 2014;53:180\u20135. https:\/\/doi.org\/10.1093\/rheumatology\/ket330.","journal-title":"Rheumatology (Oxford)"},{"key":"1245_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","volume":"96","author":"A Fava","year":"2019","unstructured":"Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun. 2019;96:1\u201313. https:\/\/doi.org\/10.1016\/j.jaut.2018.11.001.","journal-title":"J Autoimmun"},{"key":"1245_CR3","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/S0140-6736(24)00398-2","volume":"403","author":"A Hoi","year":"2024","unstructured":"Hoi A, Igel T, Mok CC, Arnaud L. Systemic lupus erythematosus. Lancet. 2024;403:2326\u201338. https:\/\/doi.org\/10.1016\/S0140-6736(24)00398-2.","journal-title":"Lancet"},{"key":"1245_CR4","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1177\/0961203317696593","volume":"26","author":"R Aljohani","year":"2017","unstructured":"Aljohani R, Gladman DD, Su J, Urowitz MB. Disease evolution in late-onset and early-onset systemic lupus erythematosus. Lupus. 2017;26:1190\u20136. https:\/\/doi.org\/10.1177\/0961203317696593.","journal-title":"Lupus"},{"key":"1245_CR5","first-page":"20","volume":"25","author":"RF Knopf","year":"1959","unstructured":"Knopf RF, Castor CW. Systemic lupus erythematosus in an elderly patient: a case report. Med Bull (Ann Arbor). 1959;25:20\u20134.","journal-title":"Med Bull (Ann Arbor)"},{"key":"1245_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3899\/jrheum.080957","volume":"37","author":"S Lalani","year":"2010","unstructured":"Lalani S, Pope J, de Leon F, Peschken C, Members of Ca, N. F. o. L. Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study. J Rheumatol. 2010;37:38\u201344. https:\/\/doi.org\/10.3899\/jrheum.080957.","journal-title":"J Rheumatol"},{"key":"1245_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/01.md.0000147737.57861.7c","volume":"83","author":"J Boddaert","year":"2004","unstructured":"Boddaert J, Huong DLT, Amoura Z, et al. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore). 2004;83:348\u201359. https:\/\/doi.org\/10.1097\/01.md.0000147737.57861.7c.","journal-title":"Medicine (Baltimore)"},{"key":"1245_CR8","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1136\/ard.50.10.702","volume":"50","author":"J Font","year":"1991","unstructured":"Font J, Pallares L, Cervera R, et al. Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis. 1991;50:702\u20135. https:\/\/doi.org\/10.1136\/ard.50.10.702.","journal-title":"Ann Rheum Dis"},{"key":"1245_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/ard.57.7.437","volume":"57","author":"CT Ho","year":"1998","unstructured":"Ho CT, Mok CC, Lau CS, Wong RW. Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis. 1998;57:437\u201340. https:\/\/doi.org\/10.1136\/ard.57.7.437.","journal-title":"Ann Rheum Dis"},{"key":"1245_CR10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00296-016-3450-2","volume":"36","author":"S Sousa","year":"2016","unstructured":"Sousa S, Goncalves MJ, Ines LS, et al. Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register. Rheumatol Int. 2016;36:955\u201360. https:\/\/doi.org\/10.1007\/s00296-016-3450-2.","journal-title":"Rheumatol Int"},{"key":"1245_CR11","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/art.1780241002","volume":"24","author":"HA Wilson","year":"1981","unstructured":"Wilson HA, Hamilton ME, Spyker DA, et al. Age influences the clinical and serologic expression of systemic lupus erythematosus. Arthritis Rheum. 1981;24:1230\u20135. https:\/\/doi.org\/10.1002\/art.1780241002.","journal-title":"Arthritis Rheum"},{"key":"1245_CR12","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1177\/0961203312450087","volume":"21","author":"MD Alonso","year":"2012","unstructured":"Alonso MD, Martinez-Vazquez F, de Teran TD, et al. Late-onset systemic lupus erythematosus in Northwestern Spain: differences with early-onset systemic lupus erythematosus and literature review. Lupus. 2012;21:1135\u201348. https:\/\/doi.org\/10.1177\/0961203312450087.","journal-title":"Lupus"},{"key":"1245_CR13","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1177\/09612033241281507","volume":"33","author":"N Sakurai","year":"2024","unstructured":"Sakurai N, Yoshimi R, Yajima N, et al. Characteristic features of late-onset systemic lupus erythematosus: an observational study of data from the Lupus Registry of Nationwide Institutions. Lupus. 2024;33:1306\u201316. https:\/\/doi.org\/10.1177\/09612033241281507.","journal-title":"Lupus"},{"key":"1245_CR14","first-page":"505","volume":"15","author":"H Jonsson","year":"1988","unstructured":"Jonsson H, Nived O, Sturfelt G. The effect of age on clinical and serological manifestations in unselected patients with systemic lupus erythematosus. J Rheumatol. 1988;15:505\u20139.","journal-title":"J Rheumatol"},{"key":"1245_CR15","first-page":"153","volume":"17","author":"S Stefanidou","year":"2013","unstructured":"Stefanidou S, Gerodimos C, Benos A, et al. Clinical expression and course in patients with late onset systemic lupus erythematosus. Hippokratia. 2013;17:153\u20136.","journal-title":"Hippokratia"},{"key":"1245_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/0961203313513508","volume":"23","author":"X Feng","year":"2014","unstructured":"Feng X, Zou Y, Pan W, et al. Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus. Lupus. 2014;23:327\u201334. https:\/\/doi.org\/10.1177\/0961203313513508.","journal-title":"Lupus"},{"key":"1245_CR17","unstructured":"Department of Economic and Social Affairs, U. N. World Population Prospects 2019 Volume II: Demographic Profiles (United Nations, 2019)."},{"key":"1245_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ard-2022-223035","volume":"82","author":"J Tian","year":"2023","unstructured":"Tian J, Zhang D, Yao X, Huang Y, Lu Q. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis. 2023;82:351\u20136. https:\/\/doi.org\/10.1136\/ard-2022-223035.","journal-title":"Ann Rheum Dis"},{"key":"1245_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejim.2023.02.004","volume":"112","author":"M Zen","year":"2023","unstructured":"Zen M, Salmaso L, Barbiellini Amidei C, et al. Mortality and causes of death in systemic lupus erythematosus over the last decade: data from a large population-based study. Eur J Intern Med. 2023;112:45\u201351. https:\/\/doi.org\/10.1016\/j.ejim.2023.02.004.","journal-title":"Eur J Intern Med"},{"key":"1245_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roaf020","author":"M Matsushita","year":"2025","unstructured":"Matsushita M, Sakai R, Yokogawa N, et al. Prevalence of systemic lupus erythematosus and age-stratified treatment trends in the Japanese population: a cross-sectional study based on the National Database of Health Insurance Claims. Mod Rheumatol. 2025. https:\/\/doi.org\/10.1093\/mr\/roaf020.","journal-title":"Mod Rheumatol"},{"key":"1245_CR21","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/rheumatology\/ker381","volume":"51","author":"EM Ball","year":"2012","unstructured":"Ball EM, Bell AL. Lupus arthritis\u2014do we have a clinically useful classification? Rheumatology (Oxford). 2012;51:771\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/ker381.","journal-title":"Rheumatology (Oxford)"},{"issue":"105","key":"1245_CR22","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","volume":"2024","author":"Kidney Disease: Improving Global Outcomes Lupus Nephritis Work, G. KDIGO","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes Lupus Nephritis Work, G. KDIGO. Clinical practice guideline for the management of LUPUS NEPHRITIS. Kidney Int. 2024;2024(105):S1\u201369. https:\/\/doi.org\/10.1016\/j.kint.2023.09.002.","journal-title":"Kidney Int"},{"key":"1245_CR23","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1136\/ard.2010.130476","volume":"69","author":"GK Bertsias","year":"2010","unstructured":"Bertsias GK, Ioannidis JP, Aringer M, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010;69:2074\u201382. https:\/\/doi.org\/10.1136\/ard.2010.130476.","journal-title":"Ann Rheum Dis"},{"key":"1245_CR24","first-page":"497","volume":"14","author":"H Hashimoto","year":"1987","unstructured":"Hashimoto H, Tsuda H, Hirano T, et al. Differences in clinical and immunological findings of systemic lupus erythematosus related to age. J Rheumatol. 1987;14:497\u2013501.","journal-title":"J Rheumatol"},{"key":"1245_CR25","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1093\/rheumatology\/keaa477","volume":"60","author":"A Riveros Frutos","year":"2021","unstructured":"Riveros Frutos A, Holgado S, Sanvisens Berge A, et al. Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER). Rheumatology (Oxford). 2021;60:1793\u2013803. https:\/\/doi.org\/10.1093\/rheumatology\/keaa477.","journal-title":"Rheumatology (Oxford)"},{"key":"1245_CR26","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/pgmj.68.800.440","volume":"68","author":"I Domenech","year":"1992","unstructured":"Domenech I, Aydintug O, Cervera R, et al. Systemic lupus erythematosus in 50 year olds. Postgrad Med J. 1992;68:440\u20134. https:\/\/doi.org\/10.1136\/pgmj.68.800.440.","journal-title":"Postgrad Med J"},{"key":"1245_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5152\/eurasianjmed.2018.18022","volume":"51","author":"S Cildag","year":"2019","unstructured":"Cildag S, Kara Y, Cakir E, Cildag MB, Senturk T. Comparison of clinical and laboratory findings in patients with systemic lupus erythematosus with regard to age at onset. Eurasian J Med. 2019;51:17\u201321. https:\/\/doi.org\/10.5152\/eurasianjmed.2018.18022.","journal-title":"Eurasian J Med"},{"key":"1245_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1191\/096120300678828109","volume":"9","author":"SJ Pu","year":"2000","unstructured":"Pu SJ, Luo SF, Wu YJ, Cheng HS, Ho HH. The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus. 2000;9:96\u2013100. https:\/\/doi.org\/10.1191\/096120300678828109.","journal-title":"Lupus"},{"key":"1245_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00296-006-0284-3","volume":"27","author":"M Padovan","year":"2007","unstructured":"Padovan M, Govoni M, Castellino G, et al. Late onset systemic lupus erythematosus: no substantial differences using different cut-off ages. Rheumatol Int. 2007;27:735\u201341. https:\/\/doi.org\/10.1007\/s00296-006-0284-3.","journal-title":"Rheumatol Int"},{"key":"1245_CR30","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1191\/0961203303lu469xx","volume":"12","author":"P Lopez","year":"2003","unstructured":"Lopez P, Mozo L, Gutierrez C, Suarez A. Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus. 2003;12:860\u20135. https:\/\/doi.org\/10.1191\/0961203303lu469xx.","journal-title":"Lupus"},{"key":"1245_CR31","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1002\/1529-0131(199810)41:10<1714::AID-ART3>3.0.CO;2-U","volume":"41","author":"GS Cooper","year":"1998","unstructured":"Cooper GS, Dooley MA, Treadwell EL, et al. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum. 1998;41:1714\u201324. https:\/\/doi.org\/10.1002\/1529-0131(199810)41:10%3c1714::AID-ART3%3e3.0.CO;2-U.","journal-title":"Arthritis Rheum"},{"key":"1245_CR32","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.3389\/fimmu.2018.02279","volume":"9","author":"VR Moulton","year":"2018","unstructured":"Moulton VR. Sex hormones in acquired immunity and autoimmune disease. Front Immunol. 2018;9:2279. https:\/\/doi.org\/10.3389\/fimmu.2018.02279.","journal-title":"Front Immunol"},{"key":"1245_CR33","first-page":"913","volume":"29","author":"P Maddison","year":"2002","unstructured":"Maddison P, Farewell V, Isenberg D, et al. The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol. 2002;29:913\u20137.","journal-title":"J Rheumatol"},{"key":"1245_CR34","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1177\/0961203314563134","volume":"24","author":"LJ Catoggio","year":"2015","unstructured":"Catoggio LJ, Soriano ER, Imamura PM, et al. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup? Lupus. 2015;24:788\u201395. https:\/\/doi.org\/10.1177\/0961203314563134.","journal-title":"Lupus"},{"key":"1245_CR35","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/09612033241238052","volume":"33","author":"G Adeogun","year":"2024","unstructured":"Adeogun G, Camai A, Suh A, Wheless L, Barnado A. Comparison of late-onset and non-late-onset systemic lupus erythematosus individuals in a real-world electronic health record cohort. Lupus. 2024;33:525\u201331. https:\/\/doi.org\/10.1177\/09612033241238052.","journal-title":"Lupus"},{"key":"1245_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-073980","volume":"383","author":"EF Morand","year":"2023","unstructured":"Morand EF, Fernandez-Ruiz R, Blazer A, Niewold TB. Advances in the management of systemic lupus erythematosus. BMJ. 2023;383:e073980. https:\/\/doi.org\/10.1136\/bmj-2022-073980.","journal-title":"BMJ"},{"key":"1245_CR37","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00296-009-1087-0","volume":"30","author":"JB Feng","year":"2010","unstructured":"Feng JB, Ni JD, Yao X, et al. Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus: 1,790 cases. Rheumatol Int. 2010;30:1017\u201323. https:\/\/doi.org\/10.1007\/s00296-009-1087-0.","journal-title":"Rheumatol Int"},{"key":"1245_CR38","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/0961203307088006","volume":"17","author":"LA Ramirez Gomez","year":"2008","unstructured":"Ramirez Gomez LA, Uribe Uribe O, Osio Uribe O, et al. Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children. Lupus. 2008;17:596\u2013604. https:\/\/doi.org\/10.1177\/0961203307088006.","journal-title":"Lupus"},{"key":"1245_CR39","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1191\/0961203305lu2245oa","volume":"14","author":"MA Garcia","year":"2005","unstructured":"Garcia MA, Marcos JC, Marcos AI, et al. Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus. 2005;14:938\u201346. https:\/\/doi.org\/10.1191\/0961203305lu2245oa.","journal-title":"Lupus"},{"key":"1245_CR40","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1177\/0961203321991920","volume":"30","author":"K Chanprapaph","year":"2021","unstructured":"Chanprapaph K, Tubtieng I, Pratumchat N, et al. Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients. Lupus. 2021;30:785\u201394. https:\/\/doi.org\/10.1177\/0961203321991920.","journal-title":"Lupus"},{"key":"1245_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.55563\/clinexprheumatol\/oo5ymg","volume":"41","author":"I Prevete","year":"2023","unstructured":"Prevete I, Iuliano A, Cauli A, et al. Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus. Clin Exp Rheumatol. 2023;41:145\u201350. https:\/\/doi.org\/10.55563\/clinexprheumatol\/oo5ymg.","journal-title":"Clin Exp Rheumatol"},{"key":"1245_CR42","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00005792-198509000-00001","volume":"64","author":"MC Hochberg","year":"1985","unstructured":"Hochberg MC, Boyd RE, Ahearn JM, et al. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore). 1985;64:285\u201395.","journal-title":"Medicine (Baltimore)"},{"key":"1245_CR43","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/art.21765","volume":"54","author":"AM Bertoli","year":"2006","unstructured":"Bertoli AM, Alarcon GS, Calvo-Alen J, et al. Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease. Arthritis Rheum. 2006;54:1580\u20137. https:\/\/doi.org\/10.1002\/art.21765.","journal-title":"Arthritis Rheum"},{"key":"1245_CR44","first-page":"557","volume":"69","author":"MN Manoussakis","year":"1987","unstructured":"Manoussakis MN, Tzioufas AG, Silis MP, et al. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol. 1987;69:557\u201365.","journal-title":"Clin Exp Immunol"},{"key":"1245_CR45","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/0961203317716789","volume":"27","author":"IW Sohn","year":"2018","unstructured":"Sohn IW, Joo YB, Won S, Bae SC. Late-onset systemic lupus erythematosus: is it \u201cmild lupus\u201d? Lupus. 2018;27:235\u201342. https:\/\/doi.org\/10.1177\/0961203317716789.","journal-title":"Lupus"},{"key":"1245_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000830","author":"D D\u2019Cruz","year":"2023","unstructured":"D\u2019Cruz D, Eriksson G, Green Y, et al. Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data. Lupus Sci Med. 2023. https:\/\/doi.org\/10.1136\/lupus-2022-000830.","journal-title":"Lupus Sci Med."},{"key":"1245_CR47","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/mr\/roae011","volume":"34","author":"M Kojima","year":"2024","unstructured":"Kojima M, Sugihara T, Kawahito Y, et al. Consensus statement on the management of late-onset rheumatoid arthritis. Mod Rheumatol. 2024;34:1095\u2013102. https:\/\/doi.org\/10.1093\/mr\/roae011.","journal-title":"Mod Rheumatol"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-025-01245-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-025-01245-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-025-01245-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T01:05:59Z","timestamp":1761699959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-025-01245-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1245"],"URL":"https:\/\/doi.org\/10.1007\/s40266-025-01245-x","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ryusuke Yoshimi has received speaker fees from GlaxoSmithKline PLC, AstraZeneca PLC, and Sanofi S.A. Natsuki Sakurai and Hideaki Nakajima have no conflict to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent to participate\/publish"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data and code availability"}},{"value":"N.S.: conceptualization, validation, and writing\u2014original draft preparation. R.Y.: conceptualization, validation, and writing\u2014review and editing. H.N.: writing\u2014review and editing. All authors read and approved the final version of this manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors contributions"}}]}}